The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...
GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD ...
The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...
The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...
A new clinic in Stratford is offering ketamine treatment to help people with mental health conditions.Ketamine has been used ...
Hosted on MSN6d
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowA nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...
For those with major depression, there is a new treatment option - one that offers hope when patients are not responding to existing treatment. The ...
The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...
An estimated 21 million American adults suffer from clinical depression. © 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
How can you make therapy work best for you? Here are a few tips. And a new study offers more evidence that teens are in trouble.
CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback